Schedule 13G ownership disclosure
XILIO THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 98422T100
Event date: 2025-06-05
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Frazier Life Sciences Public Fund, L.P.
Shares: 3,508,661.00 · Class: 6.3%
- FHMLSP, L.P.
Shares: 3,508,661.00 · Class: 6.3%
- FHMLSP, L.L.C.
Shares: 3,508,661.00 · Class: 6.3%
- Frazier Life Sciences Public Overage Fund, L.P.
Shares: 1,035,069.00 · Class: 2.0%
- FHMLSP Overage, L.P.
Shares: 1,035,069.00 · Class: 2.0%
- FHMLSP Overage, L.L.C.
Shares: 1,035,069.00 · Class: 2.0%
- Frazier Life Sciences X, L.P.
Shares: 144,829.00 · Class: 0.3%
- FHMLS X, L.P.
Shares: 144,829.00 · Class: 0.3%
- FHMLS X, L.L.C.
Shares: 144,829.00 · Class: 0.3%
- Frazier Life Sciences XI, L.P.
Shares: 385,637.00 · Class: 0.7%
- FHMLS XI, L.P.
Shares: 385,637.00 · Class: 0.7%
- FHMLS XI, L.L.C.
Shares: 385,637.00 · Class: 0.7%
- Frazier Life Sciences XII, L.P.
Shares: 672,997.00 · Class: 1.3%
- FHMLS XII, L.P.
Shares: 672,997.00 · Class: 1.3%
- FHMLS XII, L.L.C.
Shares: 672,997.00 · Class: 1.3%
- James N. Topper
Shares: 5,747,193.00 · Class: 9.9%
- Patrick J. Heron
Shares: 5,747,193.00 · Class: 9.9%
- Albert Cha
Shares: 4,543,730.00 · Class: 8.1%
- James Brush
Shares: 4,543,730.00 · Class: 8.1%
- Daniel Estes
Shares: 1,058,634.00 · Class: 2.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-016985
- Form type
- SCHEDULE 13G
- Filer
- Frazier Life Sciences Public Fund, L.P.
- CIK
- CIK 1863769
- Filed
- Jun 12, 2025
- Reporting period
- Jun 05, 2025
- Description
- Schedule 13G beneficial ownership